Stock A243070 HUONS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Huons Co., Ltd.

Equities

A243070

KR7243070000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
33,800 KRW +0.45% Intraday chart for Huons Co., Ltd. -0.15% -11.98%
Mar. 27 PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd. CI
Mar. 20 Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
CI
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
CI
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.
CI
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
South Korea's Huons to Export Anesthetics to Canada
MT
GenEdit Inc. amended terms of the transaction
CI
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%
MT
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant
MT
GenEdit Inc. announced that it expects to receive $30 million in funding
CI
Haemato : to Seek EU Approval for Botox Product
MT
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor
CI
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor
CI
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors
CI
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
CI
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.
CI
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A243070 Stock
  4. News Huons Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW